Siltbuster launches integrated chemical dosing system
Water treatment specialist Siltbuster has launched an integrated chemical dosing system (iCDS) to sit alongside its range of treatment solutions.
The new product, developed and manufactured in the UK, has been designed for sites which require a compact solution, but offers many of the benefits associated with its larger containerised dosing systems.
The new chemical dosing system is built for rapid site deployment and has been sized to easily fit standard transport layouts. The iCDS has also been fitted with multiple lifting mechanism options, ensuring all site loading and unloading possibilities are catered for.
Rich Matthews, Siltbuster managing director, said: “It is fantastic to be adding a new product to our existing range of treatment solutions. The iCDS is a testament to the Siltbuster team’s continuous research, innovation and engineering capabilities, as well as their commitment to working closely with customers to achieve responsive solutions. This year is already looking like a busy year and this launch provides further flexibility and response with Siltbuster solutions.”
The iCDS offers a standard two-stage dosing system designed to dose coagulants and flocculants on a flow proportional basis.
The iCDS is capable of treating flow rates of over 100mᶾ/hr and follows the same modular principle as all of Siltbuster’s products.
This enables it to be used as a stand-alone unit or incorporated using a range of other products to create a rapidly deployed, fully operational system.
The new product, developed and manufactured in the UK, has been designed for sites which require a compact solution, but offers many of the benefits associated with its larger containerised dosing systems.
The new chemical dosing system is built for rapid site deployment and has been sized to easily fit standard transport layouts. The iCDS has also been fitted with multiple lifting mechanism options, ensuring all site loading and unloading possibilities are catered for.
Rich Matthews, Siltbuster managing director, said: “It is fantastic to be adding a new product to our existing range of treatment solutions. The iCDS is a testament to the Siltbuster team’s continuous research, innovation and engineering capabilities, as well as their commitment to working closely with customers to achieve responsive solutions. This year is already looking like a busy year and this launch provides further flexibility and response with Siltbuster solutions.”
The iCDS offers a standard two-stage dosing system designed to dose coagulants and flocculants on a flow proportional basis.
The iCDS is capable of treating flow rates of over 100mᶾ/hr and follows the same modular principle as all of Siltbuster’s products.
This enables it to be used as a stand-alone unit or incorporated using a range of other products to create a rapidly deployed, fully operational system.
